ArticleDiscover oncology2026
Integrated single-cell multi-omics analysis unveils heterogeneity in the prostate cancer tumor microenvironment.
Article in Discover oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundProstate cancer (PCa) is a heterogeneous disease characterised by a highly complex cellular ecosystem within its tumour microenvironment (TME). However, the crosstalk patterns between tumour and immune cells remain poorly understood.
methodsSingle cell RNA sequencing, spatial transcriptomics and bulk RNA-seq data were integrated to explore key Tregs cells modules and genes involved in PCa processes in the tumour microenvironment.
resultsWe found that the oxidative phosphorylation and apoptosis signaling pathways of Tregs cells in PCa patients is significantly activated. Tregs cells and Tumour cells may interact through PPIA-BSG ligand-receptor pairs to form an immunosuppressive microenvironment. Using high-dimensional weighted gene co-expression network analysis, we identified 6 key functional modules in Tregs from PCa. The spatial localization of these modules in tumor tissues was further validated using spatial transcriptomics data. Subsequent differential modules analysis revealed that the M2 module exhibited the most significant changes. A Cox proportional hazards model was then constructed based on this module, leading to the identification of 8 key prognostic genes, including ANKRD37, CHORDC1, DOK2, HSPA6, RGCC, SERPINH1, STIP1, and UBB. These genes hold promise as potential molecular markers for the diagnosis and prognostic evaluation of PCa.
conclusionThese findings reveal potential ligand-receptor interactions in the tumour microenvironment of PCa patients and key Tregs cell module genes involved in the formation of an immunosuppressive microenvironment. Targeting these cells and genes will help advance the treatment of PCa.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.